Frost & Sullivan announced today that recent analysis finds that the demand for telehealth technology is expected to rise amid the COVID-19 pandemic. The analysis, titled “Telehealth — A Technology-Based Weapon in the War Against the Coronavirus, 2020,” revealed that, as COVID-19 continues to disrupt the practice of medicine and the delivery of healthcare, the […]
Makers of high-value medical devices such as MRI machines will likely swallow the cost of the U.S.-China trade war, but that means cutting R&D and other costs, according to a new report from Frost & Sullivan. The report — “U.S.-China Tariff War Implications for the Healthcare Industry” — also predicts that when it comes to […]
The business of precision medical imaging is poised to take off in the next few years, according to a new analysis by Frost & Sullivan. The market research firm’s report, “Growth Opportunities in Precision Medical Imaging, Forecast to 2022,” said new technologies and processes in diagnostic and therapeutic imaging could spur the market to grow […]
Venture capital funding isn’t what it used to be for medical device startups, but there are actually reasons to feel optimistic about medtech funding. That was the big takeaway from a four-expert panel at DeviceTalks Minnesota last month. (The next DeviceTalks is Oct. 2 in Boston.) Charlie Whelan, director of transformational health consulting at Frost & Sullivan, […]
Emerging markets might not be all they’re cracked up to be for healthcare companies, according to a Frost & Sullivan report, as protectionist import policies and competition from generics prove to be big challenges.
Markets the so-called BRIC countries – Brazil, Russia, India and China – aren’t proving to be as easy to penetrate as healthcare companies once thought, according to F&S partner Reenita Das.